Based on record review and staff interview, it has been determined that the facility failed to develop and maintain policies and procedures for the facility to act on pharmacy identified irregularities marked as Clinical Priority) for 1 of 1 resident reviewed for the use of Clozapine (Clozaril, an atypical antipsychotic medication prescribed for treatment-resistant schizophrenia, recurrent suicidal behavior in schizophrenia), Resident ID #1. Findings are as follows: Review of an article published by the National Library of Medicine, nlm.nih.gov dated 7/1/2019 reveals that abrupt discontinuation of Clozapine has the risk to cause seizures, rebound psychosis, cholinergic rebound (profuse sweating, headache, nausea, vomiting, and diarrhea), serotonin syndrome (agitation, insomnia, high blood… …
F756 citations in Rhode Island
Drug regimen review · Pharmacy Service Deficiencies
Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity reporting guidelines in developed policies and procedures.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2025
Rhode Island cites F756 more often than its own record predicts
1.75 times the share F756 takes of citations nationally.
Of every deficiency written in Rhode Island in 2025, this is the portion that was F756.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Rhode Island surveyors wrote
F756 findings written in Rhode Island, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
Based on clinical record review and staff interview, the facility failed to ensure that monthly pharmacy recommendations were acted upon for 2 of 3 residents reviewed, Resident ID #s 10 and 11.Findings are as follows:Review of a facility policy titled, Medication Regimen Review and Reporting [MRR] dated 1/2024 states in part, .The consultant pharmacist reviews the medication regimen and medical chart of each resident at least monthly to appropriately monitor the medication regimen.The findings are communicated to the director of nursing or designee and the medical director.Resident-specific MRR recommendations and findings are documented and acted upon by the nursing care center and/or physician.The nursing care center follows up on the recommendations to verify that appropriate action has… …
The short window
Recent years
| Year | Share of Rhode Island citations | vs expected |
|---|---|---|
| 2023 | 1.14% | 1.21× |
| 2024 | 1.18% | 1.45× |
| 2025 | 1.39% | 1.75× |
Shares of citations, not counts: earlier years hold fewer inspections.
What else Rhode Island surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction